# Marwynn Holdings, Inc.: overview

MWYN · Nasdaq · CIK 2030522 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Apr 30

Pages: [Overview](/companies/mwyn.md) · [Financials](/companies/mwyn/financials.md) · [Filings](/companies/mwyn/filings.md) · [Insiders](/companies/mwyn/insiders.md)

Latest reported revenue: [$1.1m](/filings/0001213900-26-099746.md) for Q1 FY2027, three months to 2026-07-31, from the 10-Q filed Sep 14, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-099746).

## Last eight quarters

| Line item | Unit | period not labelled (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [43.8](/filings/0001213900-25-124130.md) | [624](/filings/0001213900-26-028659.md) | [43.8 d](/filings/0001213900-26-083383.md) | [41.3](/filings/0001213900-26-099746.md) | [43.8](/filings/0001213900-25-124130.md) | [1,384](/filings/0001213900-26-028659.md) | [2,774 d](/filings/0001213900-26-083383.md) | [1,090](/filings/0001213900-26-099746.md) |
| Gross margin | % | [100.0%](/filings/0001213900-25-124130.md) | [39.2%](/filings/0001213900-26-028659.md) | [99.5% d](/filings/0001213900-26-083383.md) | [99.9%](/filings/0001213900-26-099746.md) | [100.0%](/filings/0001213900-25-124130.md) | [6.0%](/filings/0001213900-26-028659.md) | [17.4% d](/filings/0001213900-26-083383.md) | [21.6%](/filings/0001213900-26-099746.md) |
| Operating margin | % | [(563.4%)](/filings/0001213900-25-124130.md) | [13.5%](/filings/0001213900-26-028659.md) | [(8360.1%) d](/filings/0001213900-26-083383.md) | [(6383.6%)](/filings/0001213900-26-099746.md) | [(797.2%)](/filings/0001213900-25-124130.md) | [(39.9%)](/filings/0001213900-26-028659.md) | [9.1% d](/filings/0001213900-26-083383.md) | [(7.7%)](/filings/0001213900-26-099746.md) |
| Net margin | % | [(261.4%)](/filings/0001213900-26-028659.md) | [3.8%](/filings/0001213900-26-028659.md) | [(9094.8%) d](/filings/0001213900-26-083383.md) | [(6593.3%)](/filings/0001213900-26-099746.md) | [(2048.7%)](/filings/0001213900-26-028659.md) | [(39.6%)](/filings/0001213900-26-028659.md) | [8.8% d](/filings/0001213900-26-083383.md) | [(10.0%)](/filings/0001213900-26-099746.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0001213900-25-124130.md) | [0.00](/filings/0001213900-26-028659.md) | not reported | [(0.16)](/filings/0001213900-26-099746.md) | [(0.05)](/filings/0001213900-25-124130.md) | [(0.03)](/filings/0001213900-26-028659.md) | not reported | [(0.01)](/filings/0001213900-26-099746.md) |
| Free cash flow | $k | not reported | not reported | [(5,035) d](/filings/0001213900-26-083383.md) | not reported | not reported | not reported | not reported | [(329)](/filings/0001213900-26-099746.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY (2024-04-30) | FY2025 (2025-04-30) | FY2026 (2026-04-30) |
| --- | --- | ---: | ---: | ---: |
| Revenue | $m | [11.9](/filings/0001213900-25-073744.md) | [0.8](/filings/0001213900-26-083383.md) | [4.2](/filings/0001213900-26-083383.md) |
| Gross margin | % | [44.8%](/filings/0001213900-25-073744.md) | [46.7%](/filings/0001213900-26-083383.md) | [15.3%](/filings/0001213900-26-083383.md) |
| Operating margin | % | [11.7%](/filings/0001213900-25-073744.md) | [(541.3%)](/filings/0001213900-26-083383.md) | [(77.3%)](/filings/0001213900-26-083383.md) |
| Net margin | % | [8.4%](/filings/0001213900-25-073744.md) | [(546.8%)](/filings/0001213900-26-083383.md) | [(92.4%)](/filings/0001213900-26-083383.md) |
| Diluted EPS | $ per share | [0.07](/filings/0001213900-25-073744.md) | [(0.29)](/filings/0001213900-26-083383.md) | [(0.21)](/filings/0001213900-26-083383.md) |
| Free cash flow | $m | [0.9](/filings/0001213900-25-073744.md) | [(5.3)](/filings/0001213900-26-083383.md) | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mwyn/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $162.1k | 152,878 |  | Added +137,112 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $88.0k | 82,991 |  | New +82,991 |
| [XTX Topco Ltd](/funds/1828301.md) | 2026-06-30 | $40.0k | 37,747 |  | Added +27,451 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $29.0k | 27,354 |  | Reduced −11,554 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $27.4k | 25,853 |  | New +25,853 |
| [TWO SIGMA SECURITIES, LLC](/funds/1450144.md) | 2026-06-30 | $19.2k | 18,159 |  | New +18,159 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $8.7k | 8,169 |  | Added +5,168 |
| [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $6.9k | 6,472 |  | Added +2,288 |
| [HRT FINANCIAL LP](/funds/1475597.md) | 2026-06-30 | $25 | 24,056 |  | New +24,056 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $15 | 14 |  | New +14 |

## Recent filings

[All 82 filings](/companies/mwyn/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:01 ET | [DEF 14A](/filings/0001213900-26-114373.md) | Proxy statement, period 2026-12-16 | 0001213900-26-114373 |
| 2026-10-20 | 16:05 ET | [8-K](/filings/0001213900-26-111022.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-111022 |
| 2026-10-13 | 16:35 ET | [8-K/A](/filings/0001213900-26-109042.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-109042 |
| 2026-10-09 | 08:00 ET | [8-K](/filings/0001213900-26-108218.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-108218 |
| 2026-09-28 | 16:35 ET | [8-K](/filings/0001213900-26-104086.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-104086 |
| 2026-09-22 | 17:00 ET | [10-K/A](/filings/0001213900-26-102241.md) | Annual report, amended, period 2026-04-30 | 0001213900-26-102241 |
| 2026-09-14 | 16:35 ET | [10-Q](/filings/0001213900-26-099746.md) | Quarterly report, period 2026-07-31 | 0001213900-26-099746 |
| 2026-07-30 | 16:50 ET | [10-K](/filings/0001213900-26-083383.md) | Annual report, period 2026-04-30 | 0001213900-26-083383 |
| 2026-07-15 | 16:09 ET | [8-K](/filings/0001213900-26-078325.md) | 8.01 Other events | 0001213900-26-078325 |
| 2026-04-01 | 16:11 ET | [8-K](/filings/0001213900-26-038511.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-26-038511 |

## Latest annual report

[Form 10-K for the fiscal year ended Apr 30, 2026](/filings/0001213900-26-083383.md), filed Jul 30, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 2030522
- Tickers: MWYN
- Exchange: Nasdaq
- SIC code: 5141 Wholesale-Groceries, General Line
- State of incorporation: NV
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:03 ET. No prices; not investment advice.